Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06859515Recruiting
A Long-term Follow up Study of EXG102-031 in Participants With wAMD
Wet Age-related Macular Degeneration
PrincipalinvestigatorStart date: 2025-03-13
NCT06183814Phase 1/2Unknown
A Study of EXG102-031 in Participants With wAMD
Neovascular Age-related Macular Degeneration
PrincipalinvestigatorStart date: 2023-10-12
NCT07178249Phase 1/2Not Yet Recruiting
Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD
Wet Age-related Macular Degeneration
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking University People's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Heier, MD

Ophthalmic Consultants of Boston

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular DegenerationWet Age-Related Macular Degeneration
Similarity Score30%

Byung Jhip Ha

Sam Chun Dang Pharm. Co. Ltd.

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular DegenerationWet Age-Related Macular Degeneration
Similarity Score30%

Xiaorong Li, professor

Tianjin Medical University Eye Hospital

Related
5 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Jamie Dananberg, MD

UNITY Biotechnology

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Se Joon Woo

Seoul National University Bundang Hospital, South Korea

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

youxin chen, MD

Peking Union Medical College Hospital

Related
2 trials

Shared therapeutic areas:

Wet Age-Related Macular Degeneration
Similarity Score15%

Federico Grossi, MD PhD

Apellis Pharmaceuticals, Inc.

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Denis O'Shaughnessy, Ph.D.

Oraya Therapeutics, Inc.

Related
2 trials

Shared therapeutic areas:

Wet Age-Related Macular Degeneration
Similarity Score15%

Jeffrey S Heier, MD

Ophthalmic Consultants of Boston

Related
5 trials

Shared therapeutic areas:

Wet Age-Related Macular Degeneration
Similarity Score15%

Sharon Klier, MD, MPH

Unity Biotechnology, Inc.

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06859515PrincipalInvestigator

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Wet Age-related Macular Degeneration
Recruiting
NCT06183814Phase 1/2PrincipalInvestigator

A Study of EXG102-031 in Participants With wAMD

Neovascular Age-related Macular Degeneration
Unknown
NCT07178249Phase 1/2PrincipalInvestigator

Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD

Wet Age-related Macular Degeneration
Not Yet Recruiting

All 3 trials loaded